Bis-Pro-5FU, a precursor to 5-Fluorouracil (5-FU), enhances the oral bioavailability and safety profile of 5-FU chemotherapy treatments. 5-FU itself is an antineoplastic antimetabolite extensively utilized in the research of colorectal and pancreatic cancer.